Scientists have been working at a blistering pace to shorten the vaccine development cycle from years to months in order to take a coronavirus vaccine to market. With more than 190 such vaccines in development, there are several leading the pack.
Two trials, by AstraZeneca and Johnson & Johnson, had been halted because participants had become sick. But both were cleared to resume in recent days.
Here’s the latest on the development of vaccines, as of Oct. 15, according to The New York Times and the World Health Organization:
For more information on how the coronavirus is affecting midsize businesses, please visit the RSM Coronavirus Resource Center.
